534 related articles for article (PubMed ID: 16092078)
1. Effective bisquaternary reactivators of tabun-inhibited AChE.
Kuca K; Cabal J; Musilek K; Jun D; Bajgar J
J Appl Toxicol; 2005; 25(6):491-5. PubMed ID: 16092078
[TBL] [Abstract][Full Text] [Related]
2. In vitro reactivation of tabun-inhibited acetylcholinesterase using new oximes--K027, K005, K033 and K048.
Kuca K; Cabal J
Cent Eur J Public Health; 2004 Mar; 12 Suppl():S59-61. PubMed ID: 15141981
[TBL] [Abstract][Full Text] [Related]
3. Bisquaternary oximes as reactivators of tabun-inhibited human brain cholinesterases: an in vitro study.
Kuca K; Jun D; Cabal J; Musilova L
Basic Clin Pharmacol Toxicol; 2007 Jul; 101(1):25-8. PubMed ID: 17577312
[TBL] [Abstract][Full Text] [Related]
4. An evaluation of therapeutic and reactivating effects of newly developed oximes (K156, K203) and commonly used oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice.
Kassa J; Karasova J; Musilek K; Kuca K
Toxicology; 2008 Jan; 243(3):311-6. PubMed ID: 18054821
[TBL] [Abstract][Full Text] [Related]
5. A comparison of tabun-inhibited rat brain acetylcholinesterase reactivation by three oximes (HI-6, obidoxime, and K048) in vivo detected by biochemical and histochemical techniques.
Bajgar J; Hajek P; Zdarova JK; Kassa J; Paseka A; Slizova D; Krs O; Kuca K; Jun D; Fusek J; Capek L
J Enzyme Inhib Med Chem; 2010 Dec; 25(6):790-7. PubMed ID: 21054236
[TBL] [Abstract][Full Text] [Related]
6. A comparison of the reactivating and therapeutic efficacy of newly developed bispyridinium oximes (K250, K251) with commonly used oximes against tabun in rats and mice.
Kassa J; Karasova J; Bajgar J; Kuca K; Musilek K; Kopelikova I
J Enzyme Inhib Med Chem; 2009 Aug; 24(4):1040-4. PubMed ID: 19552519
[TBL] [Abstract][Full Text] [Related]
7. A comparison of reactivating and therapeutic efficacy of bispyridinium acetylcholinesterase reactivator KR-22934 with the oxime K203 and commonly used oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice.
Kassa J; Karasova JZ; Pavlikova R; Musilek K; Kuca K; Bajgar J; Jung YS
Toxicol Mech Methods; 2011 Mar; 21(3):241-5. PubMed ID: 21142778
[TBL] [Abstract][Full Text] [Related]
8. Novel series of bispyridinium compounds bearing a (Z)-but-2-ene linker--synthesis and evaluation of their reactivation activity against tabun and paraoxon-inhibited acetylcholinesterase.
Musilek K; Holas O; Kuca K; Jun D; Dohnal V; Opletalova V; Dolezal M
Bioorg Med Chem Lett; 2007 Jun; 17(11):3172-6. PubMed ID: 17383875
[TBL] [Abstract][Full Text] [Related]
9. [A comparison of the efficacy of the reactivators of acetylcholinesterase inhibited with tabun].
Cabal J; Kuca K; Jun D; Bajgar J; Hrabinová M
Ceska Slov Farm; 2005 Jul; 54(4):192-5. PubMed ID: 16124202
[TBL] [Abstract][Full Text] [Related]
10. In vitro reactivation potency of acetylcholinesterase reactivators--K074 and K075--to reactivate tabun-inhibited human brain cholinesterases.
Kuca K; Cabal J; Jun D; Musilek K
Neurotox Res; 2007 Feb; 11(2):101-6. PubMed ID: 17449453
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo evaluation of pyridinium oximes: mode of interaction with acetylcholinesterase, effect on tabun- and soman-poisoned mice and their cytotoxicity.
Calić M; Vrdoljak AL; Radić B; Jelić D; Jun D; Kuca K; Kovarik Z
Toxicology; 2006 Feb; 219(1-3):85-96. PubMed ID: 16332406
[TBL] [Abstract][Full Text] [Related]
12. A comparison of reactivating and therapeutic efficacy of the oxime K203 and its fluorinated analog (KR-22836) with currently available oximes (obidoxime, trimedoxime, HI-6) against tabun in rats and mice.
Kassa J; Karasova JZ; Caisberger F; Musilek K; Kuca K; Jung YS
J Enzyme Inhib Med Chem; 2010 Aug; 25(4):480-4. PubMed ID: 20233085
[TBL] [Abstract][Full Text] [Related]
13. Effect of five acetylcholinesterase reactivators on tabun-intoxicated rats: induction of oxidative stress versus reactivation efficacy.
Pohanka M; Karasova JZ; Musilek K; Kuca K; Kassa J
J Appl Toxicol; 2009 Aug; 29(6):483-8. PubMed ID: 19338015
[TBL] [Abstract][Full Text] [Related]
14. A comparison of reactivating efficacy of newly developed oximes (K074, K075) and currently available oximes (obidoxime, HI-6) in cyclosarin-and tabun-poisoned rats.
Kassa J; Jun D; Kuca K
J Enzyme Inhib Med Chem; 2007 Jun; 22(3):297-300. PubMed ID: 17674811
[TBL] [Abstract][Full Text] [Related]
15. In vitro reactivating effects of standard and newly developed oximes on malaoxon-inhibited mouse brain acetylcholinesterase.
dos Santos AA; dos Santos DB; Dafre AL; de Bem AF; Souza DO; da Rocha JB; Kuca K; Farina M
Basic Clin Pharmacol Toxicol; 2010 Sep; 107(3):768-73. PubMed ID: 20406208
[TBL] [Abstract][Full Text] [Related]
16. A comparison of the potency of newly developed oximes (K074, K075) and commonly used oximes (obidoxime, HI-6) to counteract tabun-induced neurotoxicity in rats.
Kassa J; Karasova J
Toxicology; 2007 Jan; 229(1-2):136-44. PubMed ID: 17141392
[TBL] [Abstract][Full Text] [Related]
17. Changes of rat plasma total low molecular weight antioxidant level after tabun exposure and consequent treatment by acetylcholinesterase reactivators.
Pohanka M; Karasova JZ; Musilek K; Kuca K; Jung YS; Kassa J
J Enzyme Inhib Med Chem; 2011 Feb; 26(1):93-7. PubMed ID: 20569082
[TBL] [Abstract][Full Text] [Related]
18. A comparison of reactivating efficacy of newly developed oximes (K074, K075) and currently available oximes (obidoxime, HI-6) in soman, cyclosarin and tabun-poisoned rats.
Kassa J; Jun D; Karasova J; Bajgar J; Kuca K
Chem Biol Interact; 2008 Sep; 175(1-3):425-7. PubMed ID: 18547554
[TBL] [Abstract][Full Text] [Related]
19. In vitro investigation of efficacy of new reactivators on OPC inhibited rat brain acetylcholinesterase.
Atanasov VN; Petrova I; Dishovsky C
Chem Biol Interact; 2013 Mar; 203(1):139-43. PubMed ID: 23220589
[TBL] [Abstract][Full Text] [Related]
20. A comparison of the potency of newly developed oximes (K027, K048) and commonly used oximes (obidoxime, HI-6) to counteract tabun-induced neurotoxicity in rats.
Kassa J; Kunesova G
J Appl Toxicol; 2006; 26(4):309-16. PubMed ID: 16552727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
